Trichomonas vaginalis and prostate cancer: A systematic review

Authors

DOI:

https://doi.org/10.33448/rsd-v13i4.45593

Keywords:

Trichomonas vaginalis; Prostatic neoplasms; Trichomonas infections; Prostate.

Abstract

Introduction: Prostate cancer (PC) is the second most frequent neoplasm in men accounting for 29% of tumor cases, at a rate of 1.4 million new cases and 375,000 deaths globally each year. Although its high prevalence, little is known about its etiology. Sexually transmitted infections (STIs) are one of the factors under discussion for a possible risk factor. Trichomoniasis is a prevalent STI caused by the pathogenic protozoan Trichomonas vaginalis that has been associated with the incidence of PC. Objectives: This review aims to determine whether the T. vaginalis is a risk factor for the development and/or progression of the disease. Methodology: A systematic review was conducted using the PubMed and Scielo databases. The following descriptors were used: “Prostate Cancer”; “Trichomonas vaginalis”; “Trichomonosis”; “Prostate”, all indexed in DeCS/MeSH. Results and Discussion: In total, 24 articles were included (8 in vitro studies; 1 in vivo study; 3 prospective studies; 9 case-control studies; 2 randomized clinical trials; and 1 systematic review and meta-analysis). Conclusion: Even though in vitro and in vivo studies analyzed credibly indicate the existence of this pathophysiology, these findings have not been reproduced in most populations studies conducted, throughout the years. More recent studies involving a bigger database indicates an association. This leads us to believe that new population studies should be conducted to obtain a consensus so that educational and preventive measures can be implemented.

References

Chen, Y. C., Huang, Y. L., Platz, E. A., Alderete, J. F., Zheng, L., Rider, J. R., Kraft, P., Giovannucci, E., & Sutcliffe, S. (2012). Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer. Cancer Causes & Control, 24(1), 175–180. 10.1007/s10552-012-0103-y

Chung, H.-Y., Kim, J.-H., Han, I.-H., & Ryu, J.-S. (2020). Polarization of M2 Macrophages by Interaction between Prostate Cancer Cells Treated with Trichomonas vaginalis and Adipocytes. Korean Journal of Parasitology, 58(3), 217–227. 10.3347/kjp.2020.58.3.217

Collin, S. M., Metcalfe, C., Donovan, J. L., Athene Lane, J., Davis, M., Neal, D. E., Hamdy, F. C., & Martin, R. M. (2009). Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: A case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study. European Journal of Cancer, 45(18), 3254–3261. 10.1016/j.ejca.2009.05.021

Fowke, J. H., Han, X., Alderete, J. F., Moses, K. A., Signorello, L. B., & Blot, W. J. (2016). A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men. BMC Research Notes, 9(1). 10.1186/s13104-016-2033-3

Galvão, M.C.B. & Ricarte, I.L.M. (2019). Revisão sistemática da literatura: conceituação, produção e publicação. LOGEION: Filosofia da informação. 6, 57-73. 10.21728/logeion.2019v6n1.p57-73

Han, I. H., Kim, J. H., Kim, S. S., Ahn, M. H., & Ryu, J. S. (2016). Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis. Parasite Immunology, 38(11), 678–687. 10.1111/pim.12357

Han, I., Kim, J., Jang, K., & Ryu, J. (2019). Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells. The Prostate, 79(10), 1133–1146. 10.1002/pros.23826

Han, I.-H., Song, H.-O., & Ryu, J.-S. (2020). IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages. PLOS Neglected Tropical Diseases, 14(3), e0008126. 10.1371/journal.pntd.0008126

Hordern, A., & Street, A. (2007). Issues of Intimacy and Sexuality in the Face of Cancer. Cancer Nursing, 30(6), E11–E18. 10.1097/01.ncc.0000300162.13639.f5

Kamarkhani, Z., Rafiei-Sefiddashti, R., Haghighi, L., & Badirzadeh, A. (2021). Molecular Examination of Trichomonas vaginalis Infection and Risk of Prostate Cancer in the Biopsy of Patients with Different Prostate Lesions. Ethiopian Journal of Health Sciences, 31(2). 10.4314/ejhs.v31i2.5

Kim, J.-H., Moon, H.-S., Kim, K.-S., Hwang, H.-S., Ryu, J.-S., & Park, S.-Y. (2019). Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men. The Korean Journal of Parasitology, 57(1), 21–25. 10.3347/kjp.2019.57.1.21

Kim, K.-S., Moon, H.-S., Kim, S.-S., & Ryu, J.-S. (2021a). Involvement of Macrophages in Proliferation of Prostate Cancer Cells Infected with Trichomonas vaginalis. The Korean Journal of Parasitology, 59(6), 557–564. 10.3347/kjp.2021.59.6.557

Kim, S.-S., Kim, K.-S., Han, I., Kim, Y., Bang, S., Kim, J.-H., Kim, Y.-S., Choi, S., & Ryu, J. (2021b). Proliferation of Mouse Prostate Cancer Cells Inflamed by Trichomonas vaginalis. Korean Journal of Parasitology, 59(6), 547–556. 10.3347/kjp.2021.59.6.547

Kolonel, L. N., Nomura, A. M. Y., & Cooney, R. V. (1999). Dietary Fat and Prostate Cancer: Current Status. JNCI Journal of the National Cancer Institute, 91(5), 414–428. 10.1093/jnci/91.5.414

Kushwaha, B., Devi, A., Maikhuri, J. P., Rajender, S., & Gupta, G. (2020). Inflammation driven tumor-like signaling in prostatic epithelial cells by sexually transmitted Trichomonas vaginalis. International Journal of Urology, 28(2), 225–240. 10.1111/iju.14431

Langston, M. E., Bhalla, A., Alderete, J. F., Nevin, R. L., Pakpahan, R., Hansen, J., Elliott, D., Marzo, A. M., Gaydos, C. A., Isaacs, W. B., Nelson, W. G., Sokoll, L. J., Zenilman, J. M., Platz, E. A., & Sutcliffe, S. (2019). Trichomonas vaginalis infection and prostate‐specific antigen concentration: Insights into prostate involvement and prostate disease risk. The Prostate, 79(14), 1622–1628. 10.1002/pros.23886

MacInnis, R. J., & English, D. R. (2006). Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes & Control, 17(8), 989–1003. 10.1007/s10552-006-0049-z

Marous, M., Huang, W.-Y., Rabkin, C. S., Hayes, R. B., Alderete, J. F., Rosner, B., Grubb, R. L., Winter, A. C., & Sutcliffe, S. (2017). Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial. Cancer Causes & Control, 28(8), 889–898. 10.1007/s10552-017-0919-6

Najafi, A., Chaechi Nosrati, M. R., Ghasemi, E., Navi, Z., Yousefi, A., Majidiani, H., Ghaneialvar, H., Sayehmiri, K., Galvan-Ramirez, M. D. la L., & Fakhar, M. (2019). Is there association between Trichomonas vaginalis infection and prostate cancer risk?: A systematic review and meta-analysis. Microbial Pathogenesis, 137, 103752. 10.1016/j.micpath.2019.103752

Neves, D. P. (2012). Parasitologia humana. Atheneu.

Saleh, N. E., Alhusseiny, S. M., El-Zayady, W. M., Aboelnaga, E. M., Wafaa El-Beshbishi, Saleh, Y., Hala Samir Abou-ElWafa, & El-Beshbishi, S. N. (2020). Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study. Parasitology Research, 120(4), 1379–1388. 10.1007/s00436-020-06942-7

Shui, I. M., Kolb, S., Hanson, C., Sutcliffe, S., Rider, J. R., & Stanford, J. L. (2016). Trichomonas vaginalis infection and risk of advanced prostate cancer. The Prostate, 76(7), 620–623. 10.1002/pros.23153

Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48. 10.3322/caac.21763

Stark, J. R., Judson, G., Alderete, J. F., Mundodi, V., Kucknoor, A. S., Giovannucci, E. L., Platz, E. A., Sutcliffe, S., Fall, K., Kurth, T., Ma, J., Stampfer, M. J., & Mucci, L. A. (2009). Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians’ Health Study. JNCI: Journal of the National Cancer Institute, 101(20), 1406–1411. 10.1093/jnci/djp306

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.

Sutcliffe, S. (2006). Plasma Antibodies against Trichomonas vaginalis and Subsequent Risk of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention, 15(5), 939–945. 10.1158/1055-9965.epi-05-0781

Sutcliffe, S., Alderete, J. F., Till, C., Goodman, P. J., Hsing, A. W., Zenilman, J. M., De Marzo, A. M., & Platz, E. A. (2009). Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. International Journal of Cancer, 124(9), 2082–2087. 10.1002/ijc.24144

Sutcliffe, S., Neace, C., Magnuson, N. S., Reeves, R., & Alderete, J. F. (2012). Trichomonosis, a Common Curable STI, and Prostate Carcinogenesis—A Proposed Molecular Mechanism. PLoS Pathogens, 8(8), e1002801. 10.1371/journal.ppat.1002801

Tsang, S. H., Peisch, S. F., Rowan, B., Markt, S. C., Gonzalez-Feliciano, A. G., Sutcliffe, S., Platz, E. A., Mucci, L. A., & Ebot, E. M. (2019). Association between Trichomonas vaginalis and prostate cancer mortality. International Journal of Cancer, 144(10), 2377–2380. 10.1002/ijc.31885

Twu, O., Dessí, D., Vu, A., Mercer, F., Stevens, G. C., de Miguel, N., Rappelli, P., Cocco, A. R., Clubb, R. T., Fiori, P. L., & Johnson, P. J. (2014). Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proceedings of the National Academy of Sciences of the United States of America, 111(22), 8179–8184. 10.1073/pnas.1321884111

Vicier, C., Werner, L., Chipman, J., Harshman, L. C., Patil, D., Fichorova, R. N., Rider, J. R., Sanda, M. G., Mucci, L. A., & Sweeney, C. J. (2019). Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer. Clinical Genitourinary Cancer, 17(1), 32–37. 10.1016/j.clgc.2018.09.022

Vollmer, R. T. (2002). Prostate Biopsy Interpretation. Archives of Pathology & Laboratory Medicine, 126(12), 1560–1560. /10.5858/2002-126-1560-pbi

Yang, H.Y., Su, R.Y., Chung, C.-H., Huang, K.Y., Lin, H.A., Wang, J.Y., Chen, C.C., Chien, W.C., & Lin, H.C. (2022). Association between trichomoniasis and prostate and bladder diseases: a population-based case–control study. Scientific Reports, 12(1), 15358. 10.1038/s41598-022-19561-2

Downloads

Published

26/04/2024

How to Cite

LOPES, M. L. .; OLIVEIRA, J. V. de .; FONSECA, F. L. A. .; LOPES, L. S. .; GEHRKE, F. de S. . Trichomonas vaginalis and prostate cancer: A systematic review. Research, Society and Development, [S. l.], v. 13, n. 4, p. e9913445593, 2024. DOI: 10.33448/rsd-v13i4.45593. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/45593. Acesso em: 16 may. 2024.

Issue

Section

Review Article